Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Blind Randomized Controlled Trial to Assess the Safety and Efficacy of High Dose Pulse Intravenous Corticosteroid Therapy to Treat Patients With Complicated/Fulminant Acute Myocarditis

NCT05150704 is registered in ClinicalTrials.gov with Niguarda Hospital as lead sponsor.

NCT NCT05150704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05150704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Blind Randomized Controlled Trial to Assess the Safety and Efficacy of High Dose Pulse Intravenous Corticosteroid Therapy to Treat Patients With Complicated/Fulminant Acute Myocarditis
Lead sponsor
Niguarda Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
October 7, 2021
Completion date
December 31, 2028
Enrollment
288 (estimated)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

myocarditis acute